AMENDMENT NO. 2 TO LICENSE AGREEMENTLicense Agreement • March 18th, 2011 • Quark Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Amendment No. 2 to License Agreement (the “Second Amendment”) is made and entered into as of March 4, 2011 (the “Second Amendment Effective Date”) by and between Quark Pharmaceuticals, Inc., (formerly Quark Biotech, Inc.) a California corporation having a place of business at 6501 Dumbarton Circle, Fremont, CA 94555 (“Quark”), and Pfizer Inc., a Delaware corporation having a place of business at 235 East 42nd Street, New York, New York 10017 (“Pfizer”). Quark and Pfizer are individually referred to as a “Party” or collectively as the “Parties”.
DISTRIBUTION AGREEMENTDistribution Agreement • March 18th, 2011 • Quark Pharmaceuticals Inc • Pharmaceutical preparations
This agreement (the “Agreement”) effective as of March , 2011, is made between Quark Pharmaceuticals, Inc. a California corporation having a place of business at 6501 Dumbarton Circle, Fremont, CA 94555 (the “Company”), and Clal Finance Underwriting Ltd., of 37 Menachem Begin, Tel Aviv, a company duly organized and existing under the laws of the State of Israel (“Clal”). Each of the Company and Clal shall be known as a “Party” and together the “Parties”.
